首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Recombinant Human B2M Protein, C-His tag

Recombinant Human B2M Protein, C-His tag

产品编号

KMH539

别名

B2M蛋白, IMD43, beta 2 microglobulin

规格
  • 20ug
  • 50ug
  • 100ug
  • 200ug
  • 1mg
产品介绍
Catalog NumberKMH539
AliasB2M蛋白, IMD43, beta 2 microglobulin
Size20ug, 50ug, 100ug, 200ug, 1mg
Product DescriptionKMH539 Recombinant Human B2M Protein, C-His tag contains the human B2M(21-119 aa) was expressed in Mammalian cells.
Molecular NameB2M
Product Introduction (KMH539) B2M是主要的免疫分子,在MHC I类分子中发挥重要作用,参与抗原呈递。
Molecular Weight13 kDa
Expression SystemHEK293F Cells
SpeciesHuman
Concentration联系销售经理获得最新批次的浓度
Purity≥95%
SDS-PAGE
PurificationAffinity Purification
Uniprot IDP61769
Storage ConditionStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
FormulationSupplied as solution form in 150mM NaCl, 50mM Tris-HCl, pH 8.0./ Lyophilized from 150mM NaCl, 50mM Tris-HCl, pH 8.0.
Shipping ConditionThis product is shipped on ice packs or dry ice.
BackgroundBeta-2-microglobulin (B2M), is a component of MHC class I molecules which belongs to the beta-2-microglobulin family. B2M is present on all nucleated cells (excludes red blood cells). B2M associates not only with the alpha chain of MHC class I molecules, but also with class I-like molecules such as CD1 and Qa. An additional function of B2M is association with the HFE protein, together regulating the expression of hepcidin in the liver which targets the iron transporter ferroportin on the cytoplasmic membrane of enterocytes and macrophages for degradation resulting in decreased iron uptake from food and iron release from recycled red blood cells respectively. Loss of this function causes iron excess and hemochromatosis. Defects in B2M are the cause of hypercatabolic hypoproteinemia (HYCATHYP).
Endotoxin< 0.1 EU per ug
Protein FamilyOther protein
Biological ActivityImmobilized Recombinant Human B2M at 2 μg/mL (100 μL/well) can bind Recombinant Human CD8 alpha with a linearrange of 30-350 ng/mL.
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 已表达的蛋白能否用于疫苗开发?

    是的,重组蛋白可以用于疫苗的开发,特别是在生产抗原性蛋白和研究免疫反应方面。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价